Most bought healthcare stocks in Q1 2026
See which Healthcare stocks institutional investors increased the most in Q1 2026, measured as net growth in reported share positions from Q4 2025 into Q1 2026. Notable additions at the top of this list include AVANTOR INC (AVTR), EMBECTA CORP (EMBC), FRESENIUS MEDICAL CARE-ADR (FMS), VERASTEM INC (VSTM). These rankings are based on SEC 13F filings from the investors we track.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AVTR | AVANTOR INC | 3,693,028 | -$61.18M | 2 | 2 | 0 | 1 | 4 |
| EMBC | EMBECTA CORP | 1,324,669 | $4.57M | 0 | 1 | 0 | 2 | 1 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 320,261 | -$11.36M | 1 | 1 | 0 | 0 | 2 |
| VSTM | VERASTEM INC | 298,958 | $1.58M | 1 | 0 | 0 | 0 | 1 |
| AMGN | AMGEN INC | 210,240 | $76.85M | 2 | 0 | 2 | 1 | 4 |
| TFX | TELEFLEX INC | 199,863 | $22.69M | 1 | 1 | 0 | 1 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 169,700 | $5.11M | 1 | 0 | 0 | 0 | 1 |
| ABBV | ABBVIE INC | 125,744 | $26.24M | 2 | 2 | 0 | 3 | 4 |
| GMED | GLOBUS MEDICAL INC - A | 80,351 | $6.92M | 1 | 0 | 0 | 0 | 1 |
| LPTX | LEAP THERAPEUTICS INC | 48,000 | $38.14K | 1 | 0 | 0 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | 39,742 | $318.73K | 1 | 0 | 0 | 0 | 1 |
| RVTY | REVVITY INC | 38,644 | $3.39M | 1 | 0 | 0 | 0 | 1 |
| COO | COOPER COS INC/THE | 34,217 | $2.45M | 2 | 0 | 0 | 0 | 2 |
| ELAN | ELANCO ANIMAL HEALTH INC | 25,218 | $603.46K | 1 | 0 | 0 | 0 | 1 |
| VVOS | VIVOS THERAPEUTICS INC | 24,000 | $28.32K | 1 | 0 | 0 | 0 | 1 |
| DGX | QUEST DIAGNOSTICS INC | 22,830 | $5.30M | 1 | 0 | 1 | 0 | 2 |
| IMNM | IMMUNOME INC | 19,127 | $418.31K | 1 | 0 | 0 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | 17,885 | $1.39M | 1 | 2 | 0 | 2 | 3 |
| RDNT | RADNET INC | 17,344 | -$509.36K | 1 | 0 | 0 | 1 | 1 |
| OPK | OPKO HEALTH INC | 16,264 | $18.54K | 1 | 0 | 0 | 0 | 1 |
| CMPX | COMPASS THERAPEUTICS INC | 15,535 | $82.18K | 1 | 0 | 0 | 0 | 1 |
| RXRX | RECURSION PHARMACEUTICALS-A | 15,162 | $46.55K | 1 | 0 | 0 | 0 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | 14,742 | $344.82K | 1 | 0 | 0 | 0 | 1 |
| KRYS | KRYSTAL BIOTECH INC | 9,725 | $2.55M | 2 | 0 | 0 | 1 | 2 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 4,769 | $159.11K | 1 | 0 | 0 | 2 | 1 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 4,560 | $1.51M | 1 | 0 | 0 | 0 | 1 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 3,602 | $225.85K | 1 | 0 | 0 | 0 | 1 |
| ITGR | INTEGER HOLDINGS CORP | 3,038 | $267.34K | 1 | 0 | 0 | 0 | 1 |
| GKOS | GLAUKOS CORP | 2,077 | $223.61K | 1 | 0 | 0 | 0 | 1 |
| ARGX | ARGENX SE - ADR | 1,961 | $1.43M | 1 | 0 | 0 | 0 | 1 |
| BGNE | BEIGENE LTD-ADR | 1,628 | $483.47K | 1 | 0 | 0 | 0 | 1 |
| LGND | LIGAND PHARMACEUTICALS | 1,204 | $240.38K | 1 | 0 | 0 | 0 | 1 |
| PEN | PENUMBRA INC | 874 | $287.00K | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2026
What are the most bought Healthcare stocks in Q1 2026?
The most bought healthcare stocks in Q1 2026 are those with the largest increase in reported share counts across tracked institutional investors compared to Q4 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2026?
Among the managers we track, net additions were largest in companies such as AVANTOR INC (AVTR), EMBECTA CORP (EMBC), FRESENIUS MEDICAL CARE-ADR (FMS), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2025).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.